- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -
Promising HCV Combo May Not See Light of Day (CME/CE)
BOSTON (MedPage Today) — In a trial described by one expert as a “home run,” a combination of two investigational oral hepatitis C (HCV) medications delivered highly promising results, but its future is iffy.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com